| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF671 ZNF28 THRA ZSCAN20 ZNF695 ZNF33A ZNF33B ZNF35 ZBED4 ZSCAN22 ZNF607 SUV39H1 ZNF66 ZNF432 ZNF343 ZFHX2 ZNF727 ZKSCAN7 ZNF736 ISL1 ZNF468 TRIM24 ZNF181 ZNF681 ZNF284 | 3.61e-09 | 1459 | 90 | 25 | GO:0000977 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF671 ZNF28 THRA ZSCAN20 ZNF695 ZNF33A ZNF33B ZSCAN22 ZNF607 ZNF66 ZNF432 ZFHX2 ZNF727 ISL2 ZKSCAN7 ZNF736 ISL1 ZNF468 TRIM24 ZNF181 ZNF681 ZNF284 | 3.29e-08 | 1271 | 90 | 22 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF28 THRA ZSCAN20 ZNF695 ZNF33A ZNF33B ZNF35 ZBED4 ZSCAN22 ZNF607 ZNF66 ZNF432 ZNF343 ZFHX2 ZNF727 ISL2 ZKSCAN7 ZNF736 ISL1 ZNF468 ZNF181 ZNF681 ZNF284 | 4.57e-08 | 1412 | 90 | 23 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF671 ZNF28 THRA ZSCAN20 ZNF695 ZNF33A ZNF33B ZSCAN22 ZNF607 ZNF66 ZNF432 ZFHX2 ZNF727 ZKSCAN7 ZNF736 ISL1 ZNF468 TRIM24 ZNF181 ZNF681 ZNF284 | 1.11e-07 | 1244 | 90 | 21 | GO:0000978 |
| GeneOntologyMolecularFunction | zinc ion binding | BLM PIKFYVE THRA KMT2B ADAMTS3 ENPP1 MARCHF8 ENPP3 SUV39H1 UBR4 ZNF343 ERVK-5 ZFHX2 ERVK-7 ERVK-24 TRIM24 MARCHF1 | 4.12e-07 | 891 | 90 | 17 | GO:0008270 |
| GeneOntologyMolecularFunction | transition metal ion binding | BLM PIKFYVE THRA KMT2B ADAMTS3 ENPP1 MARCHF8 ENPP3 SUV39H1 UBR4 ZNF343 ERVK-5 ZFHX2 ERVK-7 ERVK-24 TRIM24 MUC2 MARCHF1 | 4.93e-06 | 1189 | 90 | 18 | GO:0046914 |
| GeneOntologyMolecularFunction | sodium ion binding | 3.11e-05 | 14 | 90 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity involved in amyloid precursor protein catabolic process | 1.20e-04 | 4 | 90 | 2 | GO:1902945 | |
| GeneOntologyMolecularFunction | phosphodiesterase I activity | 1.99e-04 | 5 | 90 | 2 | GO:0004528 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.14e-04 | 26 | 90 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.14e-04 | 26 | 90 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 2.39e-04 | 27 | 90 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | neuregulin binding | 2.98e-04 | 6 | 90 | 2 | GO:0038132 | |
| GeneOntologyMolecularFunction | calcium ion binding | SNED1 NELL1 CRELD1 PLA2G12A CCBE1 ENPP1 ENPP3 JAG1 LRP1 LRP4 ADGRE1 | 5.39e-04 | 749 | 90 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | endopeptidase activity | 7.19e-04 | 430 | 90 | 8 | GO:0004175 | |
| GeneOntologyMolecularFunction | nucleoside triphosphate diphosphatase activity | 8.83e-04 | 10 | 90 | 2 | GO:0047429 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 1.52e-03 | 13 | 90 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.61e-03 | 188 | 90 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.67e-03 | 52 | 90 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | protein kinase binding | NELL1 RHOQ GFRAL FBXO5 RHOV ADAM9 LRP4 MARVELD3 USP37 ADAM10 ITGB3 | 1.86e-03 | 873 | 90 | 11 | GO:0019901 |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 3.27e-03 | 19 | 90 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 3.30e-03 | 66 | 90 | 3 | GO:0005080 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 3.41e-03 | 323 | 90 | 6 | GO:1901681 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 3.62e-03 | 20 | 90 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 3.77e-03 | 560 | 90 | 8 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 4.01e-03 | 566 | 90 | 8 | GO:0001216 | |
| GeneOntologyMolecularFunction | kinase binding | NELL1 RHOQ GFRAL FBXO5 RHOV ADAM9 LRP4 MARVELD3 USP37 ADAM10 ITGB3 | 4.15e-03 | 969 | 90 | 11 | GO:0019900 |
| GeneOntologyMolecularFunction | coreceptor activity | 4.22e-03 | 72 | 90 | 3 | GO:0015026 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing S-S bonds | 4.38e-03 | 22 | 90 | 2 | GO:0016864 | |
| GeneOntologyMolecularFunction | protein disulfide isomerase activity | 4.38e-03 | 22 | 90 | 2 | GO:0003756 | |
| GeneOntologyMolecularFunction | p53 binding | 5.09e-03 | 77 | 90 | 3 | GO:0002039 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2.44e-05 | 38 | 92 | 4 | GO:0002504 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 2.80e-05 | 270 | 92 | 8 | GO:0007160 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 3.03e-05 | 134 | 92 | 6 | GO:0003279 | |
| GeneOntologyBiologicalProcess | visceral motor neuron differentiation | 5.89e-05 | 3 | 92 | 2 | GO:0021524 | |
| GeneOntologyCellularComponent | extracellular matrix | SNED1 CRELD1 ADAMTS3 CCBE1 SPON1 PLAT MUC5B ADAM10 MUC2 PRG4 MUC5AC ITGB4 | 2.70e-05 | 656 | 91 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | SNED1 CRELD1 ADAMTS3 CCBE1 SPON1 PLAT MUC5B ADAM10 MUC2 PRG4 MUC5AC ITGB4 | 2.79e-05 | 658 | 91 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 5.19e-05 | 17 | 91 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | mucus layer | 5.61e-05 | 3 | 91 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.69e-04 | 29 | 91 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | insulin-responsive compartment | 1.00e-03 | 11 | 91 | 2 | GO:0032593 | |
| GeneOntologyCellularComponent | late endosome membrane | 1.12e-03 | 179 | 91 | 5 | GO:0031902 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.32e-03 | 109 | 91 | 4 | GO:0005796 | |
| MousePheno | abnormal vascular development | PCSK5 CRELD1 ADAMTS3 JAG1 UBR4 PLAT ISL1 ADAM10 ITGB3 ITGB4 EDN1 SMAD7 | 7.43e-06 | 542 | 66 | 12 | MP:0000259 |
| MousePheno | middle ear effusion | 8.27e-06 | 9 | 66 | 3 | MP:0030410 | |
| MousePheno | abnormal heart ventricle morphology | PIKFYVE PCSK5 THRA ERGIC3 ADAMTS3 JAG1 DEFB131B DEFB131A LRP1 PLAT ISL1 ITGB3 EDN1 SMAD7 | 1.56e-05 | 793 | 66 | 14 | MP:0005294 |
| MousePheno | increased compact bone thickness | 4.02e-05 | 41 | 66 | 4 | MP:0004148 | |
| MousePheno | decreased eosinophil cell number | 4.66e-05 | 84 | 66 | 5 | MP:0005012 | |
| MousePheno | perinatal lethality | PIKFYVE NELL1 THRA KMT2B ARL8B SCN2A UBR4 SCN9A LRP1 LRP4 ISL2 ISL1 ITGB3 ITGB4 EDN1 SMAD7 | 5.34e-05 | 1130 | 66 | 16 | MP:0002081 |
| MousePheno | abnormal tympanic cavity morphology | 5.39e-05 | 16 | 66 | 3 | MP:0030154 | |
| MousePheno | abnormal angiogenesis | 5.89e-05 | 372 | 66 | 9 | MP:0000260 | |
| MousePheno | abnormal middle ear morphology | 7.21e-05 | 92 | 66 | 5 | MP:0000049 | |
| MousePheno | abnormal cardiovascular development | PCSK5 CRELD1 KMT2B ADAMTS3 JAG1 UBR4 PLAT ISL1 ADAM10 ITGB3 ITGB4 EDN1 SMAD7 | 7.98e-05 | 802 | 66 | 13 | MP:0002925 |
| MousePheno | perinatal lethality, complete penetrance | NELL1 KMT2B ARL8B SCN2A UBR4 SCN9A LRP1 LRP4 ISL2 ISL1 ITGB4 EDN1 | 1.08e-04 | 712 | 66 | 12 | MP:0011089 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | BLM PIKFYVE NELL1 THRA KMT2B ADAMTS3 ARL8B SCN2A UBR4 SCN9A LRP1 LRP4 ISL2 ISL1 ITGB4 EDN1 | 2.10e-04 | 1269 | 66 | 16 | MP:0011111 |
| MousePheno | absent lymphatic vessels | 2.18e-04 | 5 | 66 | 2 | MP:0010194 | |
| MousePheno | abnormal blood vessel morphology | PIKFYVE PCSK5 CRELD1 ADAMTS3 CCBE1 ENPP1 ADAM9 JAG1 UBR4 PLAT ISL1 MARVELD3 ADAM10 ITGB3 ITGB4 EDN1 SMAD7 | 3.63e-04 | 1472 | 66 | 17 | MP:0001614 |
| MousePheno | decreased intestine length | 3.73e-04 | 30 | 66 | 3 | MP:0013916 | |
| MousePheno | increased susceptibility to otitis media | 4.11e-04 | 31 | 66 | 3 | MP:0001850 | |
| MousePheno | joint swelling | 4.54e-04 | 7 | 66 | 2 | MP:0002936 | |
| MousePheno | increased femur compact bone thickness | 4.54e-04 | 7 | 66 | 2 | MP:0013623 | |
| MousePheno | calcified joint | 4.54e-04 | 7 | 66 | 2 | MP:0003200 | |
| MousePheno | fusion of middle ear ossicles | 4.54e-04 | 7 | 66 | 2 | MP:0003740 | |
| Domain | - | ZNF671 PRDM10 ZNF28 ZSCAN20 ZNF695 ZNF33A ZNF33B ZNF35 ZSCAN22 ZNF532 ZNF607 ZFP64 ZNF432 ZNF343 ZFHX2 ZNF727 ZKSCAN7 ZNF736 ZNF468 ZNF181 ZNF681 ZNF284 ZNF222 | 5.10e-14 | 679 | 88 | 23 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF671 PRDM10 ZNF28 ZSCAN20 ZNF695 ZNF33A ZNF33B ZNF35 ZSCAN22 ZNF532 ZNF607 ZFP64 ZNF432 ZNF343 ZFHX2 ZNF727 ZKSCAN7 ZNF736 ZNF468 ZNF181 ZNF681 ZNF284 ZNF222 | 8.07e-14 | 694 | 88 | 23 | IPR013087 |
| Domain | zf-C2H2 | ZNF671 PRDM10 ZNF28 ZSCAN20 ZNF695 ZNF33A ZNF33B ZNF35 ZSCAN22 ZNF607 ZFP64 ZNF432 ZNF343 ZFHX2 ZNF727 ZKSCAN7 ZNF736 ZNF468 ZNF181 ZNF681 ZNF284 ZNF222 | 7.33e-13 | 693 | 88 | 22 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF671 PRDM10 ZNF28 ZSCAN20 ZNF695 ZNF33A ZNF33B ZNF35 ZSCAN22 ZNF532 ZNF607 ZFP64 ZNF432 ZNF343 ZFHX2 ZNF727 ZKSCAN7 ZNF736 ZNF468 ZNF181 ZNF681 ZNF284 ZNF222 | 8.03e-13 | 775 | 88 | 23 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF671 PRDM10 ZNF28 ZSCAN20 ZNF695 ZNF33A ZNF33B ZNF35 ZSCAN22 ZNF532 ZNF607 ZFP64 ZNF432 ZNF343 ZFHX2 ZNF727 ZKSCAN7 ZNF736 ZNF468 ZNF181 ZNF681 ZNF284 ZNF222 | 8.47e-13 | 777 | 88 | 23 | PS00028 |
| Domain | KRAB | ZNF671 ZNF28 ZSCAN20 ZNF695 ZNF33A ZNF33B ZNF607 ZNF432 ZNF343 ZNF727 ZKSCAN7 ZNF736 ZNF468 ZNF181 ZNF681 ZNF284 ZNF222 | 1.26e-12 | 369 | 88 | 17 | SM00349 |
| Domain | KRAB | ZNF671 ZNF28 ZSCAN20 ZNF695 ZNF33A ZNF33B ZNF607 ZNF432 ZNF343 ZNF727 ZKSCAN7 ZNF736 ZNF468 ZNF181 ZNF681 ZNF284 ZNF222 | 1.32e-12 | 370 | 88 | 17 | IPR001909 |
| Domain | Znf_C2H2-like | ZNF671 PRDM10 ZNF28 ZSCAN20 ZNF695 ZNF33A ZNF33B ZNF35 ZSCAN22 ZNF532 ZNF607 ZFP64 ZNF432 ZNF343 ZFHX2 ZNF727 ZKSCAN7 ZNF736 ZNF468 ZNF181 ZNF681 ZNF284 ZNF222 | 1.39e-12 | 796 | 88 | 23 | IPR015880 |
| Domain | Znf_C2H2 | ZNF671 PRDM10 ZNF28 ZSCAN20 ZNF695 ZNF33A ZNF33B ZNF35 ZSCAN22 ZNF532 ZNF607 ZFP64 ZNF432 ZNF343 ZFHX2 ZNF727 ZKSCAN7 ZNF736 ZNF468 ZNF181 ZNF681 ZNF284 ZNF222 | 1.76e-12 | 805 | 88 | 23 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF671 PRDM10 ZNF28 ZSCAN20 ZNF695 ZNF33A ZNF33B ZNF35 ZSCAN22 ZNF532 ZNF607 ZFP64 ZNF432 ZNF343 ZFHX2 ZNF727 ZKSCAN7 ZNF736 ZNF468 ZNF181 ZNF681 ZNF284 ZNF222 | 1.89e-12 | 808 | 88 | 23 | SM00355 |
| Domain | KRAB | ZNF671 ZNF28 ZNF695 ZNF33A ZNF33B ZNF607 ZNF432 ZNF343 ZNF727 ZKSCAN7 ZNF736 ZNF468 ZNF181 ZNF681 ZNF284 ZNF222 | 9.84e-12 | 358 | 88 | 16 | PS50805 |
| Domain | KRAB | ZNF671 ZNF28 ZNF695 ZNF33A ZNF33B ZNF607 ZNF432 ZNF343 ZNF727 ZKSCAN7 ZNF736 ZNF468 ZNF181 ZNF681 ZNF284 ZNF222 | 9.84e-12 | 358 | 88 | 16 | PF01352 |
| Domain | EGF_1 | TMEFF1 SNED1 NELL1 CRELD1 CCBE1 ADAM9 JAG1 LRP1 LRP4 PLAT ADGRE1 ITGB3 ITGB4 | 2.04e-10 | 255 | 88 | 13 | PS00022 |
| Domain | zf-C2H2_6 | ZNF671 PRDM10 ZNF695 ZSCAN22 ZNF532 ZNF607 ZFP64 ZNF432 ZNF727 ZNF736 ZNF468 ZNF181 ZNF681 ZNF284 | 2.27e-10 | 314 | 88 | 14 | PF13912 |
| Domain | EGF-like_CS | TMEFF1 SNED1 NELL1 CRELD1 CCBE1 ADAM9 JAG1 LRP1 LRP4 PLAT ADGRE1 ITGB3 ITGB4 | 2.72e-10 | 261 | 88 | 13 | IPR013032 |
| Domain | EGF_2 | TMEFF1 SNED1 NELL1 CRELD1 CCBE1 ADAM9 JAG1 LRP1 LRP4 PLAT ADGRE1 ITGB3 ITGB4 | 3.28e-10 | 265 | 88 | 13 | PS01186 |
| Domain | EGF | TMEFF1 PCSK5 SNED1 NELL1 CRELD1 CCBE1 ADAM9 JAG1 LRP1 LRP4 PLAT ADGRE1 | 1.05e-09 | 235 | 88 | 12 | SM00181 |
| Domain | EGF-like_dom | TMEFF1 PCSK5 SNED1 NELL1 CRELD1 CCBE1 ADAM9 JAG1 LRP1 LRP4 PLAT ADGRE1 | 2.03e-09 | 249 | 88 | 12 | IPR000742 |
| Domain | EGF_3 | TMEFF1 SNED1 NELL1 CRELD1 CCBE1 ADAM9 JAG1 LRP1 LRP4 PLAT ADGRE1 | 1.35e-08 | 235 | 88 | 11 | PS50026 |
| Domain | EGF_Ca-bd_CS | 1.80e-08 | 97 | 88 | 8 | IPR018097 | |
| Domain | EGF_CA | 2.12e-08 | 99 | 88 | 8 | PS01187 | |
| Domain | VWC_out | 2.28e-08 | 19 | 88 | 5 | SM00215 | |
| Domain | ASX_HYDROXYL | 2.30e-08 | 100 | 88 | 8 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.64e-08 | 106 | 88 | 8 | IPR000152 | |
| Domain | EGF_CA | 1.09e-07 | 122 | 88 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.24e-07 | 124 | 88 | 8 | IPR001881 | |
| Domain | EGF_CA | 1.61e-07 | 86 | 88 | 7 | PF07645 | |
| Domain | VWC | 9.19e-07 | 38 | 88 | 5 | SM00214 | |
| Domain | VWF_dom | 1.53e-06 | 42 | 88 | 5 | IPR001007 | |
| Domain | Na_trans_cytopl | 2.00e-06 | 6 | 88 | 3 | PF11933 | |
| Domain | WxxW_domain | 2.00e-06 | 6 | 88 | 3 | IPR025155 | |
| Domain | Mucin2_WxxW | 2.00e-06 | 6 | 88 | 3 | PF13330 | |
| Domain | Na_trans_cytopl | 2.00e-06 | 6 | 88 | 3 | IPR024583 | |
| Domain | Somatomedin_B | 5.56e-06 | 8 | 88 | 3 | PF01033 | |
| Domain | SO | 8.32e-06 | 9 | 88 | 3 | SM00201 | |
| Domain | Growth_fac_rcpt_ | 8.93e-06 | 156 | 88 | 7 | IPR009030 | |
| Domain | EGF_extracell | 9.22e-06 | 60 | 88 | 5 | IPR013111 | |
| Domain | EGF_2 | 9.22e-06 | 60 | 88 | 5 | PF07974 | |
| Domain | Somatomedin_B_dom | 1.18e-05 | 10 | 88 | 3 | IPR001212 | |
| Domain | Na_channel_asu | 1.18e-05 | 10 | 88 | 3 | IPR001696 | |
| Domain | SMB_1 | 1.18e-05 | 10 | 88 | 3 | PS00524 | |
| Domain | SMB_2 | 1.18e-05 | 10 | 88 | 3 | PS50958 | |
| Domain | Na_trans_assoc | 1.18e-05 | 10 | 88 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 1.18e-05 | 10 | 88 | 3 | PF06512 | |
| Domain | TIL | 2.16e-05 | 12 | 88 | 3 | PF01826 | |
| Domain | C8 | 2.16e-05 | 12 | 88 | 3 | PF08742 | |
| Domain | VWFC_1 | 2.42e-05 | 36 | 88 | 4 | PS01208 | |
| Domain | Unchr_dom_Cys-rich | 2.79e-05 | 13 | 88 | 3 | IPR014853 | |
| Domain | C8 | 2.79e-05 | 13 | 88 | 3 | SM00832 | |
| Domain | EGF | 2.88e-05 | 126 | 88 | 6 | PF00008 | |
| Domain | VWFC_2 | 3.00e-05 | 38 | 88 | 4 | PS50184 | |
| Domain | TIL_dom | 3.54e-05 | 14 | 88 | 3 | IPR002919 | |
| Domain | VWD | 5.41e-05 | 16 | 88 | 3 | SM00216 | |
| Domain | VWF_type-D | 5.41e-05 | 16 | 88 | 3 | IPR001846 | |
| Domain | VWFD | 5.41e-05 | 16 | 88 | 3 | PS51233 | |
| Domain | VWD | 5.41e-05 | 16 | 88 | 3 | PF00094 | |
| Domain | CTCK_1 | 7.84e-05 | 18 | 88 | 3 | PS01185 | |
| Domain | CT | 1.46e-04 | 22 | 88 | 3 | SM00041 | |
| Domain | Retrov_capsid_C | 1.72e-04 | 59 | 88 | 4 | IPR008916 | |
| Domain | Cys_knot_C | 2.16e-04 | 25 | 88 | 3 | IPR006207 | |
| Domain | CTCK_2 | 2.16e-04 | 25 | 88 | 3 | PS01225 | |
| Domain | Somatomedin_B_chordata | 2.17e-04 | 5 | 88 | 2 | IPR020436 | |
| Domain | cEGF | 2.43e-04 | 26 | 88 | 3 | IPR026823 | |
| Domain | cEGF | 2.43e-04 | 26 | 88 | 3 | PF12662 | |
| Domain | VWC | 3.04e-04 | 28 | 88 | 3 | PF00093 | |
| Domain | NUC | 3.25e-04 | 6 | 88 | 2 | SM00477 | |
| Domain | Endonuclease_NS | 3.25e-04 | 6 | 88 | 2 | SM00892 | |
| Domain | DNA/RNA_non-sp_Endonuclease | 3.25e-04 | 6 | 88 | 2 | IPR001604 | |
| Domain | - | 3.25e-04 | 6 | 88 | 2 | 3.40.570.10 | |
| Domain | Endonuclease_NS | 3.25e-04 | 6 | 88 | 2 | PF01223 | |
| Domain | Extracellular_endonuc_su_A | 3.25e-04 | 6 | 88 | 2 | IPR020821 | |
| Domain | E-NPP | 4.54e-04 | 7 | 88 | 2 | IPR024873 | |
| Domain | Integrin_bsu_tail | 4.54e-04 | 7 | 88 | 2 | IPR012896 | |
| Domain | Integrin_B_tail | 4.54e-04 | 7 | 88 | 2 | SM01242 | |
| Domain | Integrin_B_tail | 4.54e-04 | 7 | 88 | 2 | PF07965 | |
| Domain | MARCH-like | 6.03e-04 | 8 | 88 | 2 | IPR033275 | |
| Domain | Integrin_beta | 6.03e-04 | 8 | 88 | 2 | PF00362 | |
| Domain | INB | 6.03e-04 | 8 | 88 | 2 | SM00187 | |
| Domain | Integrin_bsu_VWA | 6.03e-04 | 8 | 88 | 2 | IPR002369 | |
| Domain | Integrin_bsu | 7.73e-04 | 9 | 88 | 2 | IPR015812 | |
| Domain | Integin_beta_N | 7.73e-04 | 9 | 88 | 2 | IPR033760 | |
| Domain | INTEGRIN_BETA | 7.73e-04 | 9 | 88 | 2 | PS00243 | |
| Domain | PSI_integrin | 7.73e-04 | 9 | 88 | 2 | PF17205 | |
| Domain | Peptidase_M12B_N | 8.17e-04 | 39 | 88 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 8.17e-04 | 39 | 88 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 8.80e-04 | 40 | 88 | 3 | PS00427 | |
| Domain | Reprolysin | 8.80e-04 | 40 | 88 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 8.80e-04 | 40 | 88 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 8.80e-04 | 40 | 88 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 8.80e-04 | 40 | 88 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 9.47e-04 | 41 | 88 | 3 | IPR001762 | |
| Domain | Phosphodiest | 9.64e-04 | 10 | 88 | 2 | PF01663 | |
| Domain | Phosphodiest/P_Trfase | 9.64e-04 | 10 | 88 | 2 | IPR002591 | |
| Domain | RINGv | 1.17e-03 | 11 | 88 | 2 | PF12906 | |
| Domain | ZF_RING_CH | 1.17e-03 | 11 | 88 | 2 | PS51292 | |
| Domain | ZnF_BED | 1.17e-03 | 11 | 88 | 2 | SM00614 | |
| Domain | Znf_BED | 1.40e-03 | 12 | 88 | 2 | IPR003656 | |
| Domain | SET_dom | 1.69e-03 | 50 | 88 | 3 | IPR001214 | |
| Domain | SET | 1.69e-03 | 50 | 88 | 3 | PS50280 | |
| Domain | Ldl_recept_b | 1.93e-03 | 14 | 88 | 2 | PF00058 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | BLM ZNF671 ZNF28 THRA ZNF33A KMT2B ZNF33B ZNF607 JAG1 ZNF432 ZNF343 ZNF727 ZKSCAN7 ZNF736 ZNF468 ZNF681 ZNF222 SMAD7 | 2.93e-05 | 1387 | 64 | 18 | M734 |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.12e-04 | 21 | 64 | 3 | MM15706 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.34e-04 | 109 | 64 | 5 | MM15164 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.53e-04 | 68 | 64 | 4 | M27303 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.66e-04 | 31 | 64 | 3 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 4.03e-04 | 32 | 64 | 3 | M27455 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 4.20e-04 | 7 | 64 | 2 | M27199 | |
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 19284629 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 19718741 | ||
| Pubmed | 2.95e-08 | 181 | 92 | 8 | 37372979 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 25638393 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 7.15e-08 | 4 | 92 | 3 | 22269464 | |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 23807779 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 17471237 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 14984930 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 7.15e-08 | 4 | 92 | 3 | 29869461 | |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 12676567 | ||
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 1.78e-07 | 5 | 92 | 3 | 11062147 | |
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 8812438 | ||
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 1.78e-07 | 5 | 92 | 3 | 16188033 | |
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 19110483 | ||
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 9272948 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 3.56e-07 | 6 | 92 | 3 | 23652591 | |
| Pubmed | 1.04e-06 | 29 | 92 | 4 | 14563677 | ||
| Pubmed | 1.49e-06 | 9 | 92 | 3 | 16382098 | ||
| Pubmed | 2.91e-06 | 11 | 92 | 3 | 27224017 | ||
| Pubmed | 2.91e-06 | 11 | 92 | 3 | 15739225 | ||
| Pubmed | 4.31e-06 | 41 | 92 | 4 | 22675208 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 9315901 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 15123669 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 7513696 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 10524196 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 20346423 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 18824633 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 14871887 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 37146737 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 6.92e-06 | 2 | 92 | 2 | 14988081 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 15563276 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 17621824 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 21090681 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 24317696 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 18321860 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 22391959 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 6.92e-06 | 2 | 92 | 2 | 35776514 | |
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 6.92e-06 | 2 | 92 | 2 | 11245985 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 24327612 | ||
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 6.92e-06 | 2 | 92 | 2 | 23016767 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 27153334 | ||
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 6.92e-06 | 2 | 92 | 2 | 25172946 | |
| Pubmed | Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. | 6.92e-06 | 2 | 92 | 2 | 10632583 | |
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 6.92e-06 | 2 | 92 | 2 | 28607090 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 9344668 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 15072822 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 27503326 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 17321686 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 31030254 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 12138181 | ||
| Pubmed | Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma. | 6.92e-06 | 2 | 92 | 2 | 20731025 | |
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 6.92e-06 | 2 | 92 | 2 | 23527003 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 16540890 | ||
| Pubmed | An N-terminally acetylated Arf-like GTPase is localised to lysosomes and affects their motility. | 6.92e-06 | 2 | 92 | 2 | 16537643 | |
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 6.92e-06 | 2 | 92 | 2 | 27845589 | |
| Pubmed | Presynaptic Biogenesis Requires Axonal Transport of Lysosome-Related Vesicles. | 6.92e-06 | 2 | 92 | 2 | 30174114 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 27435107 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 26871672 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 23832517 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 23832516 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 21757542 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 16236709 | ||
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 6.92e-06 | 2 | 92 | 2 | 11587997 | |
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 6.92e-06 | 2 | 92 | 2 | 34656442 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 17203232 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 1502153 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 34058148 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 14718370 | ||
| Pubmed | Identification of hydrolytically stable and selective P2Y(1) receptor agonists. | 6.92e-06 | 2 | 92 | 2 | 18760862 | |
| Pubmed | Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells. | 6.92e-06 | 2 | 92 | 2 | 12527922 | |
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 6.92e-06 | 2 | 92 | 2 | 21653907 | |
| Pubmed | Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes. | 6.92e-06 | 2 | 92 | 2 | 11831872 | |
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 6.92e-06 | 2 | 92 | 2 | 36427316 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 32977685 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 24947519 | ||
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 6.92e-06 | 2 | 92 | 2 | 23272068 | |
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 6.92e-06 | 2 | 92 | 2 | 27729120 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 36111525 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 26237273 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 28263310 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 11445551 | ||
| Pubmed | [Interleukin-1beta induces MUC2/MUC5B gene expression in human nasal epithelial cells]. | 6.92e-06 | 2 | 92 | 2 | 20873538 | |
| Pubmed | Temporal analysis of goblet cells and mucin gene expression in murine models of allergic asthma. | 6.92e-06 | 2 | 92 | 2 | 14594655 | |
| Pubmed | Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin. | 6.92e-06 | 2 | 92 | 2 | 32348677 | |
| Pubmed | Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis. | 6.92e-06 | 2 | 92 | 2 | 24332705 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 12820724 | ||
| Pubmed | 8.72e-06 | 180 | 92 | 6 | 24104479 | ||
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 8.87e-06 | 49 | 92 | 4 | 9630514 | |
| Pubmed | 9.78e-06 | 16 | 92 | 3 | 19850875 | ||
| Pubmed | 1.19e-05 | 17 | 92 | 3 | 24257627 | ||
| Pubmed | SFRPs act as negative modulators of ADAM10 to regulate retinal neurogenesis. | 1.19e-05 | 17 | 92 | 3 | 21478884 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.42e-05 | 18 | 92 | 3 | 18834073 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 27503069 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 9016778 | ||
| Pubmed | Differential Islet-1 expression among lumbosacral spinal motor neurons in prenatal mouse. | 2.07e-05 | 3 | 92 | 2 | 19236857 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 29286856 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 25795784 | ||
| Pubmed | Regulation of dendritic cell differentiation in bone marrow during emergency myelopoiesis. | 2.07e-05 | 3 | 92 | 2 | 23833236 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 33895391 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 19608750 | ||
| Cytoband | 3p21.32 | 3.96e-05 | 5 | 92 | 2 | 3p21.32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF671 ZNF28 KMT2B ZSCAN22 ZNF607 ZNF432 ZNF468 ZNF181 ZNF284 ZNF222 | 1.41e-04 | 1192 | 92 | 10 | chr19q13 |
| Cytoband | 2q24 | 2.16e-04 | 11 | 92 | 2 | 2q24 | |
| Cytoband | 19q13.41 | 5.31e-04 | 78 | 92 | 3 | 19q13.41 | |
| Cytoband | 18q21.32 | 6.64e-04 | 19 | 92 | 2 | 18q21.32 | |
| Cytoband | 11p15.5 | 1.76e-03 | 118 | 92 | 3 | 11p15.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 2.17e-03 | 127 | 92 | 3 | chr2q24 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF671 PRDM10 ZNF28 ZSCAN20 ZNF695 ZNF33A ZNF33B ZNF35 ZSCAN22 ZNF532 ZNF607 ZFP64 ZNF432 ZNF343 ZFHX2 ZNF727 ZKSCAN7 ZNF736 ZNF468 ZNF181 ZNF681 ZNF284 ZNF222 | 2.62e-15 | 718 | 72 | 23 | 28 |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 5.00e-06 | 9 | 72 | 3 | 1203 | |
| GeneFamily | CD molecules|Mucins | 7.65e-05 | 21 | 72 | 3 | 648 | |
| GeneFamily | CD molecules|Integrin beta subunits | 5.53e-04 | 9 | 72 | 2 | 1159 | |
| GeneFamily | Ring finger proteins|Membrane associated ring-CH-type fingers | 8.40e-04 | 11 | 72 | 2 | 60 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 9.65e-04 | 394 | 72 | 7 | 471 | |
| GeneFamily | LIM class homeoboxes | 1.01e-03 | 12 | 72 | 2 | 522 | |
| GeneFamily | Low density lipoprotein receptors | 1.19e-03 | 13 | 72 | 2 | 634 | |
| GeneFamily | Rho family GTPases | 2.84e-03 | 20 | 72 | 2 | 390 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 5.15e-03 | 27 | 72 | 2 | 47 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 6.75e-03 | 31 | 72 | 2 | 357 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 8.08e-03 | 34 | 72 | 2 | 487 | |
| Coexpression | NABA_MATRISOME | PCSK5 SNED1 NELL1 CRELD1 ADAMTS3 INSL6 CCBE1 SPON1 ADAM9 PLAT MUC5B ADAM10 MUC2 PRG4 MUC5AC | 1.06e-06 | 1008 | 87 | 15 | MM17056 |
| Coexpression | NABA_MATRISOME | PCSK5 SNED1 NELL1 CRELD1 ADAMTS3 INSL6 CCBE1 SPON1 ADAM9 PLAT MUC5B ADAM10 MUC2 PRG4 MUC5AC | 1.32e-06 | 1026 | 87 | 15 | M5889 |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED | 2.52e-06 | 29 | 87 | 4 | M47987 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 1.04e-05 | 41 | 87 | 4 | M47988 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 3.15e-05 | 54 | 87 | 4 | M4737 | |
| Coexpression | BRAUNE_GEIST_20_GENE_NOTCH_SIG_BREAST_CANCER | 3.87e-05 | 20 | 87 | 3 | M48357 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL | 5.48e-05 | 122 | 87 | 5 | M45802 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_DN | 5.53e-05 | 200 | 87 | 6 | M7144 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_PROGENITORS_CELL | 8.86e-05 | 135 | 87 | 5 | M45710 | |
| Coexpression | COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN | 9.83e-05 | 138 | 87 | 5 | M19245 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.63e-08 | 180 | 89 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.63e-08 | 180 | 89 | 7 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.92e-08 | 181 | 89 | 7 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.51e-07 | 199 | 89 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.56e-07 | 200 | 89 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.56e-07 | 200 | 89 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-06 | 171 | 89 | 6 | 686f95892c3909973c66c9a27159a070a068f175 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-06 | 171 | 89 | 6 | f7ba03e7bdb687f93782c936c7b3374cc5b3b77c | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-06 | 171 | 89 | 6 | d0ac50071a3854d02113c455fcc940a6ec59bbb9 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-06 | 171 | 89 | 6 | fbf8e9db00573adcada4b25730e191417b7c9999 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.83e-06 | 183 | 89 | 6 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-06 | 189 | 89 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-06 | 189 | 89 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.28e-06 | 190 | 89 | 6 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-06 | 190 | 89 | 6 | d87b9e9ca863270a9c7f61674271a6440c97d1f4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-06 | 191 | 89 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-06 | 191 | 89 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.42e-06 | 192 | 89 | 6 | 285a9d332a1e07b94f222d4b518dd56928b9e075 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.42e-06 | 192 | 89 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-06 | 193 | 89 | 6 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-06 | 194 | 89 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-06 | 194 | 89 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.97e-06 | 199 | 89 | 6 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 89 | 6 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 89 | 6 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 166 | 89 | 5 | 3b67064a5149e72f895344d938c64b8ff65247f5 | |
| ToppCell | Club-club-2|World / Class top | 2.08e-05 | 166 | 89 | 5 | 56f11efb6b686b3ee2c34a051f626e3d761b5112 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 171 | 89 | 5 | a474aaed3ca4cacb0ab565c35f25d92a10f531b7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 171 | 89 | 5 | 992df143d76f9e7fb1997a8996f61e941f0f9d4f | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 2.47e-05 | 172 | 89 | 5 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.54e-05 | 173 | 89 | 5 | 1f725ff16e28636b20ef26f3fa9be8b47c89378d | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 173 | 89 | 5 | 295bfe1efa648173c2d5981025bc61c576baf53f | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-05 | 174 | 89 | 5 | cdfc50e5383c8670ce5109736aff36406f46c03d | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 2.75e-05 | 176 | 89 | 5 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.91e-05 | 178 | 89 | 5 | 9f59a9af232d77bb55603a7776dbf9749ea652f2 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 179 | 89 | 5 | b7281160c84dd053a2981c9c76ea6cc6d2592cd5 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.07e-05 | 180 | 89 | 5 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 181 | 89 | 5 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 182 | 89 | 5 | aa113a0d2c1d28bda24cbb1221afd21b5628dc6d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-05 | 183 | 89 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 184 | 89 | 5 | 1e54fd372c6e6a298f427b807c14cc49aaaffe80 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 185 | 89 | 5 | ff95a45b7cb782961bb8f008b6b507af2d4cb8b7 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-05 | 186 | 89 | 5 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.68e-05 | 187 | 89 | 5 | 7170694a1b86fe8d84d96c880ffe57af09bdc026 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 187 | 89 | 5 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.77e-05 | 188 | 89 | 5 | 5bc1537e079c7435196c163bff5f639ea392a33a | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 189 | 89 | 5 | 2ce330d8078833c05775c481e73770f9ee4a5c88 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.87e-05 | 189 | 89 | 5 | d17e8467699c7ca7694a313c26111f085df5204e | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 189 | 89 | 5 | 473c87036e04a058b4a5138438b7ba7e1e766799 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-05 | 190 | 89 | 5 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-duct_epithelial_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-05 | 190 | 89 | 5 | 5b3f773380aef4773b70f0dbd74992d28e6586c6 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 3.97e-05 | 190 | 89 | 5 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.97e-05 | 190 | 89 | 5 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.07e-05 | 191 | 89 | 5 | b270c3dd5952f56b9bdceabe13e298fe6757563b | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.07e-05 | 191 | 89 | 5 | 27f23c2254b610abac1a88d0fecff305addde9da | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.07e-05 | 191 | 89 | 5 | d162917816dd2e4767c97447c1cddae9397713ab | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.17e-05 | 192 | 89 | 5 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.17e-05 | 192 | 89 | 5 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.17e-05 | 192 | 89 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.17e-05 | 192 | 89 | 5 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.27e-05 | 193 | 89 | 5 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.38e-05 | 194 | 89 | 5 | d024cd75a97f048257e49cee9190fb2e79202ee2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.38e-05 | 194 | 89 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.49e-05 | 195 | 89 | 5 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.49e-05 | 195 | 89 | 5 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.60e-05 | 196 | 89 | 5 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.71e-05 | 197 | 89 | 5 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.83e-05 | 198 | 89 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.83e-05 | 198 | 89 | 5 | 5dd2aa7684c36beffa204ca4c04d0501cabac10f | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX-Bronchial_vessel|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.83e-05 | 198 | 89 | 5 | dcf334d13e5b0018fee24febccfef91c9e17843b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.94e-05 | 199 | 89 | 5 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.94e-05 | 199 | 89 | 5 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.06e-05 | 200 | 89 | 5 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.06e-05 | 200 | 89 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.06e-05 | 200 | 89 | 5 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.06e-05 | 200 | 89 | 5 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | distal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.06e-05 | 200 | 89 | 5 | 20112be28f80baffad92641c9cfd7c3718967dbb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Interneuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 121 | 89 | 4 | b2d571f571133c281d72584fe925cebbd2317829 | |
| ToppCell | Endothelial-G|World / shred on cell class and cell subclass (v4) | 1.12e-04 | 124 | 89 | 4 | 4b72809463f2986b7d1b7ab9de633ac4d7854a92 | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-04 | 136 | 89 | 4 | 82d7f90ef2a63a3137c331efd68c036cd0db3ac1 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 139 | 89 | 4 | 505bf5a483fc2ba69377db9850c3b26ab2f416d1 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.99e-04 | 144 | 89 | 4 | b622b605f7ec6083ec06c8ea0fd171e07c52f3de | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.04e-04 | 145 | 89 | 4 | e808502fa52baf1c400f3c9b918a167127e78af9 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.33e-04 | 150 | 89 | 4 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | MS-CD4-CD8_1|MS / Condition, Cell_class and T cell subcluster | 2.33e-04 | 150 | 89 | 4 | 7dc95c58b98d8c4c6c49fb1a03ec6ac24fb41f54 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.33e-04 | 150 | 89 | 4 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.45e-04 | 152 | 89 | 4 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.57e-04 | 154 | 89 | 4 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-04 | 155 | 89 | 4 | 8e239470799426ea474a36f57e1b7e0d9365ca5f | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.70e-04 | 156 | 89 | 4 | 895927228c93cd090303984c5be6ebfb59ed6f3a | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.77e-04 | 157 | 89 | 4 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-04 | 158 | 89 | 4 | d3446fc98eff09c3626b47a2c90d07cd985378b5 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-2|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.83e-04 | 158 | 89 | 4 | 9dea15b28f64206bac0e785df6f36a2cc9010ac7 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-04 | 158 | 89 | 4 | df614450e10629dc9115d7365397663e82f9e48f | |
| ToppCell | (07)_Brush-(4)_1wkpi|(07)_Brush / shred by cell type and Timepoint | 2.98e-04 | 13 | 89 | 2 | 5cb4ae18264b986e387b53624d6f74ac809900e4 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-04 | 161 | 89 | 4 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | severe_influenza-cDC|World / disease group, cell group and cell class (v2) | 3.04e-04 | 161 | 89 | 4 | 802f8cafb5f499e3b2ec0193d6eb1ac9320b9287 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-04 | 161 | 89 | 4 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-04 | 161 | 89 | 4 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | Mild-Lymphoid-NK-innate_T|Mild / Condition, Lineage, Cell class and cell subclass | 3.12e-04 | 162 | 89 | 4 | bd218e41b2eadc3bba4c7ac3e34a014f6ad8b1bf | |
| Drug | auromomycin | 2.98e-06 | 8 | 87 | 3 | CID005748693 | |
| Drug | isodApdC | 1.44e-05 | 2 | 87 | 2 | CID000477021 | |
| Drug | pinicolic acid | 1.44e-05 | 2 | 87 | 2 | CID005320604 | |
| Drug | 5-iodoindoxyl-3-phenylphosphonate | 1.44e-05 | 2 | 87 | 2 | CID000126064 | |
| Drug | hydroxymethyltrioxsalen | 2.91e-05 | 16 | 87 | 3 | CID000104953 | |
| Drug | Zonisamide | 3.53e-05 | 17 | 87 | 3 | DB00909 | |
| Drug | Scorpion Venoms | 4.22e-05 | 18 | 87 | 3 | ctd:D012604 | |
| Drug | RI-64 | 4.32e-05 | 3 | 87 | 2 | CID000065758 | |
| Drug | 4mupt | 4.32e-05 | 3 | 87 | 2 | CID000196156 | |
| Drug | phenylphosphonic dichloride | 4.32e-05 | 3 | 87 | 2 | CID000069990 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 4.32e-05 | 3 | 87 | 2 | ctd:C561228 | |
| Drug | quinovic acid | 4.32e-05 | 3 | 87 | 2 | CID000120678 | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 1.98e-06 | 9 | 86 | 3 | EFO_0009824 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.83e-06 | 10 | 86 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.83e-06 | 10 | 86 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 5.16e-06 | 12 | 86 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Coronary Thrombosis | 8.40e-06 | 2 | 86 | 2 | C0010072 | |
| Disease | cystitis (is_marker_for) | 8.40e-06 | 2 | 86 | 2 | DOID:1679 (is_marker_for) | |
| Disease | angle-closure glaucoma (is_marker_for) | 8.40e-06 | 2 | 86 | 2 | DOID:13550 (is_marker_for) | |
| Disease | sputum mucin-5B amount | 2.51e-05 | 3 | 86 | 2 | OBA_2050332 | |
| Disease | Hennekam syndrome (is_implicated_in) | 2.51e-05 | 3 | 86 | 2 | DOID:0060366 (is_implicated_in) | |
| Disease | Hennekam lymphangiectasia-lymphedema syndrome | 2.51e-05 | 3 | 86 | 2 | C0340834 | |
| Disease | cystic fibrosis (is_marker_for) | 3.30e-05 | 62 | 86 | 4 | DOID:1485 (is_marker_for) | |
| Disease | anxiety disorder (implicated_via_orthology) | 3.54e-05 | 22 | 86 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 8.35e-05 | 5 | 86 | 2 | DOID:3030 (is_marker_for) | |
| Disease | Liver Cirrhosis, Experimental | RHOQ SELENOP PLA2G12A PLAT ARL8A ADGRE1 TRIM24 ITGB3 EDN1 DUS1L | 8.55e-05 | 774 | 86 | 10 | C0023893 |
| Disease | myocardial infarction (is_implicated_in) | 2.05e-04 | 99 | 86 | 4 | DOID:5844 (is_implicated_in) | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 2.05e-04 | 99 | 86 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 2.98e-04 | 9 | 86 | 2 | C3502809 | |
| Disease | Facies | 3.72e-04 | 10 | 86 | 2 | C0282631 | |
| Disease | response to fenofibrate | 4.24e-04 | 50 | 86 | 3 | GO_1901557 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 4.24e-04 | 50 | 86 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | nephritis (biomarker_via_orthology) | 4.54e-04 | 11 | 86 | 2 | DOID:10952 (biomarker_via_orthology) | |
| Disease | pulmonary fibrosis | 4.54e-04 | 11 | 86 | 2 | EFO_0009448 | |
| Disease | Acute Cerebrovascular Accidents | 5.33e-04 | 54 | 86 | 3 | C0751956 | |
| Disease | response to beta blocker, heart rate | 6.24e-04 | 57 | 86 | 3 | EFO_0004326, EFO_0007766 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 6.41e-04 | 13 | 86 | 2 | C0751122 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 6.41e-04 | 13 | 86 | 2 | EFO_0802114 | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 6.57e-04 | 58 | 86 | 3 | DOID:10652 (biomarker_via_orthology) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 7.61e-04 | 61 | 86 | 3 | DOID:3587 (is_marker_for) | |
| Disease | Cerebrovascular accident | 7.98e-04 | 62 | 86 | 3 | C0038454 | |
| Disease | cholangiocarcinoma (is_marker_for) | 8.76e-04 | 64 | 86 | 3 | DOID:4947 (is_marker_for) | |
| Disease | Astrocytosis | 1.11e-03 | 17 | 86 | 2 | C3887640 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 1.11e-03 | 17 | 86 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | Gliosis | 1.11e-03 | 17 | 86 | 2 | C0017639 | |
| Disease | epilepsy (implicated_via_orthology) | 1.34e-03 | 163 | 86 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 1.54e-03 | 20 | 86 | 2 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | Hemorrhage | 1.54e-03 | 20 | 86 | 2 | C0019080 | |
| Disease | congenital heart disease (is_implicated_in) | 2.22e-03 | 24 | 86 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 2.89e-03 | 97 | 86 | 3 | DOID:3083 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEIKDYKARLTCPCC | 911 | Q5VTR2 | |
| ICEKYGLEECTCASS | 571 | O14672 | |
| CRGCCKKRASKETAD | 411 | Q6P1R4 | |
| YKCICAADLLSCTGL | 36 | Q86WK7 | |
| RGSLRKTGCCYSCEE | 5641 | Q9HC84 | |
| EICCYSISCKEKDNI | 156 | Q9NVJ2 | |
| EICCYSISCKEKDNI | 156 | Q96BM9 | |
| DRCYETCGKSKNDCD | 111 | Q9BZM1 | |
| EGSYECRDCAKACLG | 266 | Q96HD1 | |
| AIRYCADFSICCKLK | 46 | P59861 | |
| KTCKDFDECSVYGTC | 146 | Q07954 | |
| YEKETKECRDCHKSC | 1411 | Q92824 | |
| EDLKKCVTADKCGCY | 1176 | Q02817 | |
| RCESCYGAEAEDIKC | 141 | Q9Y282 | |
| KSSDTRCCELCKYEF | 116 | Q5T0T0 | |
| RSLCACSDDCKDKGD | 161 | P22413 | |
| CALCLKYGDADSKEA | 1581 | Q9UMN6 | |
| CTERGVECTYKAEAC | 1261 | P98088 | |
| EKIYQCTECDKAFCR | 641 | Q9NQV6 | |
| GKCGEKQERSDCYCV | 46 | P61583 | |
| GKCGEKQERSDCYCV | 46 | P61582 | |
| KSCTECVRVDKDCAY | 36 | P16144 | |
| EDRCSVCSCKDGKIF | 651 | Q92832 | |
| KSSDTRCCELCKYDF | 116 | Q8TCQ1 | |
| GKCGEKQERSDCYCV | 46 | P61581 | |
| CKECYDCSEKFTTFR | 161 | Q9Y2I7 | |
| GYNKLCCESCSKRSS | 1041 | O15072 | |
| TECDKKDGFGKCYRC | 801 | O60308 | |
| VSCDNCCKTKDYKTR | 1061 | P54132 | |
| TCLYFICKALEKDCR | 176 | Q9Y6J0 | |
| KECLCTDDFYCTVNK | 81 | Q6UXV0 | |
| SDDCLQRKDCCADYK | 116 | O14638 | |
| GSCKDCIKDYERLSC | 81 | Q9UKT4 | |
| DEDSESSKCCSIRYC | 1516 | Q5JV73 | |
| KSSGELTTCYRKKCC | 61 | Q6UXH8 | |
| TCKLKSFAECAYGDC | 446 | Q13443 | |
| EAEGLLECHKCKYLC | 181 | Q96A59 | |
| KITGKYCECDDFSCV | 541 | P05106 | |
| KRCSCSSLMDKECVY | 51 | P05305 | |
| AIRYCADFSICCKLK | 46 | A0A096LNP1 | |
| CTRDECDTYFKVCLK | 66 | P78504 | |
| CTCFVRDGKTYCKRD | 66 | Q96A47 | |
| LAKEIGACCYVECSA | 151 | P17081 | |
| ILDCCACGTAKYRLT | 196 | Q9HCB6 | |
| YKTSLCVDCDCFKEK | 281 | Q6XZB0 | |
| RRGYSEKCCLTGCTK | 171 | Q9Y581 | |
| YCSLSLKSCEKDGDD | 1006 | Q5QGS0 | |
| SYKECVCKINDDCTL | 891 | Q15858 | |
| TCDDQYCCSDVLKKF | 51 | Q8N114 | |
| KSYKECVCKINDDCT | 906 | Q9NY46 | |
| CTCFVRDGKTYCKRD | 56 | P61371 | |
| GRECDCDAQCKKYDK | 81 | Q92954 | |
| AYCEKKCGNCSLTTL | 166 | P49908 | |
| VRIECKCGTESCRKY | 396 | O43463 | |
| CTCKVGYTGEDCAKE | 891 | Q8TER0 | |
| SCKNLSGRYKCSCLD | 96 | Q14246 | |
| IFSREKCYKCEECGK | 166 | A8MUV8 | |
| KCYKCEECGKDCRLS | 171 | A8MUV8 | |
| ADRSYKCEECGKACK | 196 | A8MUV8 | |
| EKCYECNECGKTFTR | 331 | P13682 | |
| YKCLECGDSFALEKS | 616 | Q9HCE3 | |
| LKLYCETCDKLTCRD | 231 | O15164 | |
| SSEVKRLCCCESYGK | 171 | O15105 | |
| YVCLECGRSFCDKST | 381 | Q6P1L6 | |
| YICRECGRGFCDKST | 521 | Q6P1L6 | |
| YECSRCGKAFSCISK | 451 | Q8TAW3 | |
| GKCCEIDTRATCYED | 116 | P00750 | |
| KTYRCEECGKAFNLC | 266 | Q8IW36 | |
| ECYECGKTFCLKSDL | 526 | Q06732 | |
| YKCVDCGKCFSERSK | 931 | P17040 | |
| KEVAGDTHRCKLCCY | 751 | Q9C0A1 | |
| EKIRACCYLECSALT | 176 | Q96L33 | |
| YICFASREDGCCKII | 326 | O95759 | |
| SYKECVCKISNDCEL | 906 | Q99250 | |
| CKECGKSFRCASYLV | 451 | Q96SK3 | |
| CYECGKTFCLKSDLT | 526 | Q06730 | |
| KPYKCDACGRAFSDC | 406 | P10073 | |
| AEELEYSCEKCGGKC | 531 | Q86T82 | |
| IGEKSYICEECGKAC | 221 | Q96N22 | |
| EKSCICSECGRGFAK | 566 | O94892 | |
| KCKVCDKAFRSDSCL | 496 | P17035 | |
| YECSECGKAFSRSKC | 551 | Q9P0L1 | |
| CEECGEAFKYSCSLT | 371 | Q6ZN08 | |
| CKYDSCCVIDKITRN | 91 | P10827 | |
| VCDESSCKYGGVCKE | 76 | Q8IYR6 | |
| PCKEDYLAVCGLKDC | 1961 | Q5T4S7 | |
| YTVEECTCEDCIKSK | 121 | Q02223 | |
| YKCEECCKVFSRKSN | 411 | Q5VIY5 | |
| KCEFCDKCFSRKDNL | 331 | Q9NTW7 | |
| CNREKIYTCSECGKA | 231 | Q2M3W8 | |
| TCDECGKSFCYISAL | 146 | Q9UK12 | |
| DCGKRLVCRSYCKDQ | 401 | Q9UK12 | |
| KLYKCEECGRSFTCR | 341 | Q2VY69 | |
| TVERCYKCEECGKAF | 196 | B4DX44 | |
| DSLKAECRYCGCAIS | 471 | O75132 | |
| RKCSDKEFRCSDGSC | 146 | O75096 |